Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Perry Tsergas Insider Profile

4 Followers

Perry Tsergas, Director at PharmAla Biotech Holdings, Inc., holds 456.00K shares in PharmAla Biotech Holdings, Inc. (Ticker: TSE:MDMA).

Perry Tsergas's Trading History

MDMAPharmAla Biotech Holdings, Inc.		May 16, 2026DirectorUninformative Sell10.00KC$68.40K
TSE:MDMA
Insider Shares: 456.00K (41.99%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 16, 2026Uninformative SellC$10.00K100,000C$0.10――
Mar 21, 2025Uninformative SellC$0.0037,500C$0.00――
Dec 11, 2024Uninformative SellC$0.0037,500C$0.00――
Dec 03, 2024Uninformative SellC$0.0075,000C$0.00――
Nov 26, 2024Informative SellC$12.76K44,000C$0.29――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Perry Tsergas insider profile FAQ

What stocks does Perry Tsergas hold?
Perry Tsergas holds: TSE:MDMA stocks.
What was Perry Tsergas’s latest transaction?
Perry Tsergas’s latest transaction was an Uninformative Sell of C$10.00K.
What is Perry Tsergas's role in PharmAla Biotech Holdings, Inc.?
Perry Tsergas's role in PharmAla Biotech Holdings, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.